L Li Selected Research

Aftercare (After-Treatment)

2/2024	Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
5/2023	[Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages].
11/2022	[The role of Botulinum toxin type A in the treatment of childhood strabismus].
8/2021	[A multicenter, randomized, double-masked, placebo-controlled trial of compound wild chrysanthemum eye masks for mild and moderate dry eye].
1/2021	[The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma].
4/2020	[Clinical effect of nebulized acetylcysteine inhalation combined with bronchoscopy in the treatment of elderly patients with severe ventilator-associated pneumonia].
5/2019	Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanercept.
9/2016	[Efficacy of a hydrosurgery system applied in the debridement of extensive residual wounds of patients with severe burn].
2/2015	A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose-Response Curve.
4/2014	Effects of atorvastatin in combination with ezetimibe on carotid atherosclerosis in elderly patients with hypercholesterolemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Li Research Topics

Disease

204	Neoplasms (Cancer) 03/2024 - 01/2000
59	Infections 03/2024 - 03/2000
48	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2000
41	Inflammation (Inflammations) 05/2024 - 01/2000
33	Lung Neoplasms (Lung Cancer) 01/2024 - 04/2000
32	Breast Neoplasms (Breast Cancer) 09/2023 - 03/2000
30	Carcinoma (Carcinomatosis) 02/2024 - 02/2000
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 02/2000
24	Type 2 Diabetes Mellitus (MODY) 07/2023 - 05/2000
24	Insulin Resistance 04/2023 - 05/2000
23	Body Weight (Weight, Body) 10/2023 - 02/2000
23	Carcinogenesis 10/2022 - 08/2000
21	Hypoxia (Hypoxemia) 08/2021 - 04/2000
20	Hypertension (High Blood Pressure) 01/2022 - 01/2000
19	Pain (Aches) 12/2023 - 05/2000
19	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 03/2000
19	Necrosis 10/2022 - 05/2000
19	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 10/2001
18	Wounds and Injuries (Trauma) 05/2023 - 06/2000
17	Hemorrhage 10/2023 - 10/2001
17	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2022 - 01/2000
16	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 03/2000
15	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2000
15	Reperfusion Injury 12/2023 - 03/2001
15	Lymphatic Metastasis 10/2021 - 05/2000
15	Hypersensitivity (Allergy) 04/2020 - 01/2000
14	Myocardial Infarction 12/2023 - 06/2000
14	Obesity 04/2023 - 06/2000
14	Lymphoma (Lymphomas) 11/2022 - 09/2000
14	Adenocarcinoma 03/2022 - 08/2000
14	Stroke (Strokes) 10/2019 - 03/2001
13	Osteoporosis 05/2022 - 06/2010
13	Ischemia 01/2021 - 01/2000
13	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2001
13	Asthma (Bronchial Asthma) 11/2016 - 04/2000
11	Burns 03/2023 - 01/2000
11	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 10/2000
10	Tuberculosis (Tuberculoses) 05/2024 - 10/2007
10	Atrophy 04/2024 - 10/2000
10	Esophageal Squamous Cell Carcinoma 12/2023 - 01/2005
10	Hyperplasia 09/2023 - 10/2000
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 04/2000
10	Brain Ischemia (Cerebral Ischemia) 02/2023 - 03/2001
10	Leukemia 09/2022 - 03/2006
10	Sepsis (Septicemia) 06/2022 - 09/2000
10	Ovarian Epithelial Carcinoma 03/2022 - 04/2015
10	Fibrosis (Cirrhosis) 01/2021 - 11/2000
10	Melanoma (Melanoma, Malignant) 03/2019 - 12/2001
9	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 06/2001
9	Squamous Cell Carcinoma of Head and Neck 03/2022 - 05/2000
9	Nasopharyngeal Carcinoma 01/2020 - 10/2012
9	Diabetes Mellitus 01/2020 - 02/2000
9	Hepatitis B 06/2019 - 02/2011
9	Infarction (Infarctions) 04/2017 - 03/2001
8	Cataract (Cataracts) 01/2024 - 09/2000
8	Cerebral Infarction 02/2023 - 03/2001
8	Disease Progression 03/2022 - 06/2006

Drug/Important Bio-Agent (IBA)

122	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2000
43	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2001
41	Messenger RNA (mRNA)IBA 05/2024 - 02/2000
33	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 01/2000
24	CytokinesIBA 04/2023 - 04/2000
24	EnzymesIBA 03/2023 - 04/2000
24	Long Noncoding RNAIBA 03/2022 - 02/2015
23	RNA (Ribonucleic Acid)IBA 02/2024 - 03/2000
23	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2000
22	AntigensIBA 12/2017 - 04/2000
21	Insulin (Novolin)FDA Link 08/2018 - 06/2001
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 08/2000
14	Small Interfering RNA (siRNA)IBA 04/2023 - 05/2007
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 10/2001
13	CholesterolIBA 10/2023 - 05/2000
13	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 02/2000
13	AntibodiesIBA 10/2019 - 10/2000
12	MicroRNAs (MicroRNA)IBA 09/2023 - 10/2012
12	AntioxidantsIBA 05/2021 - 12/2000
11	VaccinesIBA 12/2023 - 08/2000
11	Therapeutic UsesIBA 12/2023 - 05/2000
11	Blood Glucose (Blood Sugar)IBA 05/2023 - 05/2000
11	LipidsIBA 04/2023 - 06/2000
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 07/2007
10	Anti-Bacterial Agents (Antibiotics)IBA 08/2020 - 11/2000
10	Monoclonal AntibodiesIBA 04/2020 - 04/2000
9	ImmunosorbentsIBA 03/2023 - 11/2002
9	InterleukinsIBA 03/2022 - 01/2007
9	Indicators and Reagents (Reagents)IBA 07/2021 - 06/2000
9	CalciumIBA 01/2017 - 02/2000
8	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 09/2007
8	Hemoglobins (Hemoglobin)IBA 05/2023 - 02/2000
8	CateninsIBA 04/2023 - 02/2012
8	LipopolysaccharidesIBA 06/2022 - 06/2001
8	Interleukin-6 (Interleukin 6)IBA 06/2022 - 08/2008

Therapy/Procedure

112	Therapeutics 08/2023 - 01/2000
35	Drug Therapy (Chemotherapy) 12/2023 - 06/2000
16	Radiotherapy 11/2022 - 12/2000
13	Transplantation 01/2024 - 09/2005
12	Aftercare (After-Treatment) 02/2024 - 12/2001
10	Immunotherapy 07/2022 - 02/2000
9	Length of Stay 03/2024 - 01/2011
9	Resuscitation 04/2021 - 01/2000